Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B

Journal of Medical Virology

Volumn 82, Issue 2, 2010, Pages 224-331

  Toniutto, Pierluigi ^a   Fattovich, Giovanna ^b   Fabris, Carlo ^a   Minisini, Rosalba ^c   Burlone, Michela ^c   Pravadelli, Cecilia ^b   Peraro, Laura ^b   Falleti, Edmondo ^a   Caldera, Francesca ^c   Bitetto, Davide ^a   Pirisi, Mario ^c  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Apolipoprotein E; Apolipoprotein H; Hepatitis B virus

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BETA2 GLYCOPROTEIN 1; HEPATITIS B SURFACE ANTIGEN; INTERFERON; LOW DENSITY LIPOPROTEIN RECEPTOR; NUCLEOSIDE ANALOG; PEGINTERFERON;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; RECEPTOR BINDING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS CARRIER;

HEPATITIS B VIRUS;

EID: 74549160260     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21642     Document Type: Article

References (38)

1. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. 1999. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96:12766-12771.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soci Ser B 57:289-300.
3. Bosch FX, Ribes J, Cleries R, Diaz M. 2005. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191-211, v.
4. Brown LA, Cook RT, Jerrells TR, Kolls JK, Nagy LE, Szabo G, Wands JR, Kovacs EJ. 2006. Acute and chronic alcohol abuse modulate immunity. Alcohol Clin Exp Res 30:1624-1631.
5. Cattin L, Fisicaro M, Tonizzo M, Valenti M, Danek GM, Fonda M, Da Col PG, Casagrande S, Pincetri E, Bovenzi M, Baralle F. 1997. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler Thromb Vasc Biol 17:91-94.
6. Chu CM, Liaw YF. 2007. HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up. Hepatology 45:1187-1192.
7. Eichner JE,DunnST, PerveenG, ThompsonDM,Stewart KE, Stroehla BC. 2002. Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am J Epidemiol 155:487-495.
8. Fabris C, Toniutto P, Bitetto D, Minisini R, Smirne C, Caldato M, Pirisi M. 2005. Low fibrosis progression of recurrent hepatitis C in apolipoproteinEepsilon4 carriers: Relationship with the blood lipid profile. Liver Int 25:1128-1135.
9. Fattovich G, Boscaro S, Noventa F, Pornaro E, Stenico D, Alberti A, Ruol A, Realdi G. 1987. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 155:931-935.
10. Fattovich G, Bortolotti F, Donato F. 2008. Natural history of chronic hepatitis B: Specialemphasis on disease progression and prognostic factors. J Hepatol 48:335-352.
11. Ganem D, Prince AM. 2004. Hepatitis B virus infection - Natural history and clinical consequences. N Engl J Med 350:1118-1129.
12. Gao PJ, Piao YF, Liu XD, Qu LK, Shi Y, Wang XC, Yang HY. 2003. Studies on specific interaction of beta-2-glycoprotein Iwith HBsAg. World J Gastroenterol 9:2114-2116.
13. Gomez-Coronado D, Alvarez JJ, Entrala A, Olmos JM, Herrera E, Lasuncion MA. 1999. Apolipoprotein E polymorphism in men and women from a Spanish population: Allele frequencies and influence on plasma lipids and apolipoproteins. Atherosclerosis 147:167-176.
14. Hennig BJ, Hellier S, Frodsham AJ, Zhang L, Klenerman P, Knapp S, WrightM, Thomas HC, Thursz M, Hill AV. 2002.Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection. Genes Immun 3:359-367.
15. Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD. 1998. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 28:231-236.
16. Lai CL, Yuen MF. 2007. The natural history of chronic hepatitis B. J Viral Hepat 14:6-10.
17. Li H, Liu Z, Han Q, Li Y, Chen J. 2006. Association of genetic polymorphism of low-density lipoprotein receptor with chronic viral hepatitis C infection in Han Chinese. J Med Virol 78:1289-1295.
18. Liaw YF, Chen YC, Sheen IS, Chien RN, YehCT,ChuCM.2004. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 126:1024-1029.
19. Lok AS, McMahon BJ. 2007. Chronic hepatitis B. Hepatology 45:507-539.
20. Mackay IR. 2006. Genetic susceptibility to chronic hepatitis B virus infection. J Gastroenterol Hepatol 21:1087-1088.
21. Mahley RW. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
22. Malloy SI, Altenburg MK, Knouff C, Lanningham-Foster L, Parks JS, Maeda N. 2004. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arterioscler Thromb Vasc Biol 24:91-97.
23. Manno M,CammaC, Schepis F, Bassi F,GelminiR,Giannini F, Miselli F, Grottola A, Ferretti I, Vecchi C, De Palma M, Villa E. 2004. Natural history of chronic HBV carriers in northern Italy: Morbidity and mortality after 30 years. Gastroenterology 127:756-763.
24. Mehdi H, Kaplan MJ, Anlar FY, Yang X, Bayer R, Sutherland K, Peeples ME. 1994. Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 68:2415-2424.
25. Pennings MT, van Lummel M, Derksen RH, Urbanus RT, Romijn RA, Lenting PJ, de Groot PG. 2006. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family. J Thromb Haemost 4:1680-1690.
26. Price DA, Bassendine MF, Norris SM, Golding C, Toms GL, Schmid ML, Morris CM, Burt AD, Donaldson PT. 2006. Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut 55:715-718.
27. Pumeechockchai W, Bevitt D, Agarwal K, Petropoulou T, Langer BC, Belohradsky B, Bassendine MF, Toms GL. 2002. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody. J Med Virol 68:335-342.
28. Sanghera DK, Kristensen T, Hamman RF, Kamboh MI. 1997a. Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism. Hum Genet 100:57-62.
29. Sanghera DK, Wagenknecht DR, McIntyre JA, Kamboh MI. 1997b. Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding. Hum Mol Genet 6:311-316.
30. Stefas E, Rucheton M, Graafland H, Moynier M, Sompeyrac C, Bahraoui EM, Veas F. 1997. Human plasmatic apolipoprotein H binds human immunodeficiency virus type 1 and type 2 proteins. AIDS Res Hum Retroviruses 13:97-104.
31. Stefas I, Rucheton M, D'Angeac AD, Morel-Baccard C, Seigneurin JM, Zarski JP, Martin M, Cerutti M, Bossy JP, Misse D, Graafland H, Veas F. 2001. Hepatitis B virus Dane particles bind to human plasma apolipoprotein H. Hepatology 33:207-217.
32. Toniutto P, Fabris C, Fumo E, Apollonio L, Caldato M, Mariuzzi L, AvelliniC,Minisini R, Pirisi M. 2004. Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment. Am J Clin Pathol 122:428-433.
33. Weisgraber KH. 1994. Apolipoprotein E: Structure-function relationships. Adv Protein Chem 45:249-302.
34. Weisgraber KH, Rall SC, Jr., Mahley RW. 1981. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256:9077-9083.
35. Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irving / SNM> WL.2002. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 36:456-463.
36. Wozniak MA, Faragher EB, Todd JA,Koram KA, Riley EM, Itzhaki RF. 2003. Does apolipoprotein E polymorphism influence susceptibility to malaria? J Med Genet 40:348-351.
37. Ye J. 2007. Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. PLoS Pathog 3:e108.
38. Zivelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, Seligsohn U. 1997. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 43:1657-1659.